Advances in molecular preclinical therapy mediated by imaging

Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Documenti EN

Progetti in evidenza

INCIPIT

(Link esterno)

(1209 visite)

(622 visite)

(Link esterno)

(Link esterno)

(1094 visite)

(1186 visite)

(Link esterno)

(1329 visite)

(1090 visite)

(1028 visite)

(1134 visite)

(Link esterno)

Collegamenti

▲Menu

Ricerca avanzata▼

Advances in molecular preclinical therapy mediated by imaging (67 visite) (PDF pubblico 86 visite)

Greco A, Albanese S, Auletta L, De Carlo F, Salvatore M, Howard CM, Claudio PP

Q J Nucl Med Mol Imaging (ISSN: 1827-1936electronic, 1824-4785linking), 2017 Mar; 61(1): 76-94.

Tipo di articolo: Journal Article, Review,

Impact factor: 2.481, Impact factor a 5 anni: 2.16

Url: Non disponibile.

Parole chiave: Animals, Diagnostic Imaging, Methods, Drug Delivery Systems, Humans, Neoplasms, Therapy, Precision Medicine,

Affiliazioni:

*** IBB - CNR ***
Department of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy., Ceinge, Advanced Biotechnology, Scarl, Naples, Italy., Institute of BioStructures and BioImaging, CNR, Naples, Italy., IRCCS SDN, Naples, Italy., Department of BioMolecular Sciences, National Center for Natural Products Research, University of Mississippi, Jackson, MS, USA., Department of Radiology, University of Mississippi Medical Center, Jackson, MS, USA., Department of BioMolecular Sciences, National Center for Natural Products Research, University of Mississippi, Jackson, MS, USA - pclaudio@olemiss.edu., Department of Radiation Oncology, Medical Center Cancer Institute, Jackson, MS, USA.,

Riferimenti:

Non disponibile.

Several advances have been made toward understanding the biology of cancer and most of them are due to robust genetic studies that led to the scientific recognition that although many patients have the same type of cancer their tumors may have harbored different molecular alterations. Personalized therapy and the development of advanced techniques of preclinical imaging and new murine models of disease are emerging concepts that are allowing mapping of disease markers in vivo and in some cases also receptor targeted therapy. Aim of this review is to illustrate some emerging models of disease that allow patient tumor implantation in mice for subsequent drug testing and advanced approaches for therapy mediated by preclinical imaging. In particular we discuss targeted therapy mediated by high frequency ultrasound and magnetic resonance, two emerging techniques in molecular preclinical therapy.

Characterization of the KCTD protein family: key factors in several biological processes (3507 visite)

Test e validazione di nuove sonde molecolari mediante imaging preclinico. (400 visite)

Fenotipizzazione di modelli murini mediante imaging preclinico. (686 visite)

Uso complementare dell'imaging preclinico nella ricerca sul modello animale minipig (773 visite)

Gestione clinica e terapia, procedure interventistiche, anestesia e analgesia dei modelli murini nell’ imaging preclinico (440 visite)

Valutazione dell’espressione genetica e dell’efficacia di terapie innovative mediante imaging preclinico in modelli murini (513 visite)

Protein aggregation and cytotoxicity: molecular, in vitro and in vivo biological studies (975 visite)

Translational Molecular Imaging in Cancer (400 visite)

Peptide modulators of the VEGF-dependent angiogenesis (521 visite)

Molecular imaging for personalized therapy in oncology (254 visite)

Characterization of neurotoxic and neuroprotective factors by using computational methodologies (3980 visite)

New techniques for advanced detection (429 visite)